Detalhe da pesquisa
1.
Fractionated vs single-dose gemtuzumab ozogamicin with determinants of benefit in older patients with AML: the UK NCRI AML18 trial.
Blood
; 142(20): 1697-1707, 2023 11 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37595359
2.
A randomised evaluation of low-dose cytosine arabinoside plus lenalidomide versus single-agent low-dose cytosine arabinoside in older patients with acute myeloid leukaemia: Results from the LI-1 trial.
Br J Haematol
; 204(3): 871-876, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38016651
3.
What drives CAR-T emergent cytopenia?
Br J Haematol
; 202(2): 213-214, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37009828
4.
Acute myeloid leukaemia in Afghanistan: Understanding an unfamiliar landscape.
Br J Haematol
; 203(3): 353-354, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37612135
5.
Therapy for isocitrate dehydrogenase 2 (IDH2)R172 -mutant acute myeloid leukaemia.
Br J Haematol
; 196(6): 1348-1352, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34870324
6.
A randomised comparison of FLAG-Ida versus daunorubicin combined with clofarabine in relapsed or refractory acute myeloid leukaemia: Results from the UK NCRI AML17 trial.
Br J Haematol
; 198(3): 528-534, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35388465
7.
Outcomes of older patients aged 60 to 70 years undergoing reduced intensity transplant for acute myeloblastic leukemia: results of the NCRI acute myeloid leukemia 16 trial.
Haematologica
; 107(7): 1518-1527, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34647442
8.
Characteristics and outcome of patients with acute myeloid leukaemia and t(8;16)(p11;p13): results from an International Collaborative Study.
Br J Haematol
; 192(5): 832-842, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33529373
9.
Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): an international study on 331 patients.
Blood
; 133(10): 1140-1151, 2019 03 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30610028
10.
Survivin' Acute Myeloid Leukaemia-A Personalised Target for inv(16) Patients.
Int J Mol Sci
; 22(19)2021 Sep 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34638823
11.
Evaluating sixty years of UK trials research in acute myeloid leukaemia: lessons for trial design, past, present and future.
Br J Haematol
; 188(1): 29-35, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31833053
12.
Analysis of the clinical impact of NPM1 mutant allele burden in a large cohort of younger adult patients with acute myeloid leukaemia.
Br J Haematol
; 188(6): 852-859, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31595497
13.
Combination of a mitogen-activated protein kinase inhibitor with the tyrosine kinase inhibitor pacritinib combats cell adhesion-based residual disease and prevents re-expansion of FLT3-ITD acute myeloid leukaemia.
Br J Haematol
; 191(2): 231-242, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32394450
14.
Pml nuclear body disruption cooperates in APL pathogenesis and impairs DNA damage repair pathways in mice.
Blood
; 131(6): 636-648, 2018 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29191918
15.
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party.
Blood
; 131(12): 1275-1291, 2018 03 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29330221
16.
Allogeneic hematopoietic cell transplantation improves outcome of adults with t(6;9) acute myeloid leukemia: results from an international collaborative study.
Haematologica
; 105(1): 161-169, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31004014
17.
Assessment of Minimal Residual Disease in Standard-Risk AML.
N Engl J Med
; 374(5): 422-33, 2016 Feb 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-26789727
18.
A randomized assessment of adding the kinase inhibitor lestaurtinib to first-line chemotherapy for FLT3-mutated AML.
Blood
; 129(9): 1143-1154, 2017 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27872058
19.
Variable outcome and methylation status according to CEBPA mutant type in double-mutated acute myeloid leukemia patients and the possible implications for treatment.
Haematologica
; 103(1): 91-100, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29025912
20.
Addition of the mammalian target of rapamycin inhibitor, everolimus, to consolidation therapy in acute myeloid leukemia: experience from the UK NCRI AML17 trial.
Haematologica
; 103(10): 1654-1661, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29976746